Comparative Proteomics Analysis of Serum Proteins in Gestational Diabetes during Early and Middle Stages of Pregnancy
PROTEOMICS – Clinical Applications · 2019-09 · 13 (5)
DOI: 10.1002/prca.201800060 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, online erschienen am 03.07.2019. Verfasst von Liming Shen und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Oceanography, Shenzhen University, Shenzhen, 518060, P. R. China. Hauptthemen laut MEDLINE: Proteomics. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guizhou Science and Technology Department.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Purpose
This study is designed to screen serum proteins that may serve as biomarkers for gestational diabetes mellitus (GDM), and clarify the mechanisms of disease. Experimental Design By using isobaric tags for relative and absolute quantitation proteomics analysis, serum proteins levels were quantified in pregnant women who subsequently developed GDM (12–16 weeks), GDM patients (24–28 weeks), and their corresponding controls. The strategy of mixing samples is used in proteomic analysis.
Results
Thirty‐one and 27 differentially expressed proteins are identified in the serum of pregnant women with developed GDM at 12–16 weeks and GDM patients during 24–28 weeks, respectively. Thirty eight and 28 proteins are identified in 24–28 weeks versus 12–16 weeks controls (24/12 CTR group), and 24–28 weeks GDM patients versus 12–16 weeks women with subsequently developed GDM (24/12 GDM group), respectively. Most of these proteins in the case and control subjects are associated with diabetes and maternal and perinatal short‐ and long‐term complications. Conclusions and Clinical Relevance The results highlight the roles of complement system and the blood clotting cascade in the pathogenesis of GDM. Differentially expressed proteins may serve as potential biomarkers for GDM prediction and diagnosis in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Science and Oceanography, Shenzhen University, Shenzhen, 518060, P. R. China.
- Department of Obstetrics and Gynecology, Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, P. R. China.
- School of Public Health, Guizhou Medical University, Guiyang, 550025, P. R. China.
- Maternal and Child Health Hospital of Baoan, Shenzhen, 518100, P. R. China.
ORCID-Profile: Liming Shen
Förderung
- National Natural Science Foundation of China
- Guizhou Science and Technology Department
Zitieren
APA
Shen, L., Zhao, D., Chen, Y., Zhang, K., Chen, X., Lin, J., Li, C., Iqbal, J., Zhao, Y., Liang, Y., Wei, Y., & Feng, C. (2019). Comparative Proteomics Analysis of Serum Proteins in Gestational Diabetes during Early and Middle Stages of Pregnancy. PROTEOMICS – Clinical Applications, 13(5). https://doi.org/10.1002/prca.201800060
Vancouver
Shen L, Zhao D, Chen Y, Zhang K, Chen X, Lin J, et al. Comparative Proteomics Analysis of Serum Proteins in Gestational Diabetes during Early and Middle Stages of Pregnancy. PROTEOMICS – Clinical Applications. 2019;13(5). doi:10.1002/prca.201800060
BibTeX
@article{Shen2019,
author = {Shen, Liming and Zhao, Danqing and Chen, Youjiao and Zhang, Kaoyuan and Chen, Xinqian and Lin, Jing and Li, Cuihua and Iqbal, Javed and Zhao, Yuxi and Liang, Yi and Wei, Yan and Feng, Chengyun},
title = {Comparative Proteomics Analysis of Serum Proteins in Gestational Diabetes during Early and Middle Stages of Pregnancy},
journal = {PROTEOMICS – Clinical Applications},
year = {2019},
volume = {13},
number = {5},
doi = {10.1002/prca.201800060}
}
EUVIMED